NasdaqGM - Delayed Quote USD
Maze Therapeutics, Inc. (MAZE)
13.66
+1.56
+(12.89%)
At close: June 3 at 4:00:01 PM EDT
13.66
0.00
(0.00%)
Pre-Market: 8:52:31 AM EDT
Major Holders
| Breakdown | |
|---|---|
| 5.91% | % of Shares Held by All Insider |
| 92.16% | % of Shares Held by Institutions |
| 97.95% | % of Float Held by Institutions |
| 82 | Number of Institutions Holding Shares |
Top Institutional Holders
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| TRV GP IV, LLC | 6.07M | Mar 31, 2025 | 13.87% | 82,970,265 |
| Frazier Life Sciences Management, L.P. | 4.13M | Mar 31, 2025 | 9.43% | 56,402,153 |
| Arch Venture Management, Llc | 4.12M | Mar 31, 2025 | 9.41% | 56,279,923 |
| Deep Track Capital, Lp | 3.27M | Mar 31, 2025 | 7.46% | 44,656,260 |
| Matrix Capital Management | 2.49M | Mar 31, 2025 | 5.68% | 33,961,273 |
| Alphabet Inc. | 2.41M | Mar 31, 2025 | 5.51% | 32,954,353 |
| Foresite Capital Management IV, LLC | 2.11M | Mar 31, 2025 | 4.82% | 28,848,813 |
| Ah Capital Management, L.L.C. | 1.7M | Mar 31, 2025 | 3.89% | 23,252,393 |
| Janus Henderson Group PLC | 1.25M | Mar 31, 2025 | 2.85% | 17,025,414 |
| General Catalyst Group Management, LLC | 1.04M | Mar 31, 2025 | 2.37% | 14,150,530 |
Top Mutual Fund Holders
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| AB CAP FUND, INC.-AB Small Cap Growth Portfolio | 541.28k | Mar 31, 2025 | 1.24% | 7,393,939 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 464.88k | Mar 31, 2025 | 1.06% | 6,350,206 |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 253.8k | Mar 31, 2025 | 0.58% | 3,466,907 |
| iShares Trust-iShares Russell 2000 ETF | 208.02k | Mar 31, 2025 | 0.47% | 2,841,525 |
| Fidelity Select Portfolios-Biotechnology Portfolio | 148.6k | Mar 31, 2025 | 0.34% | 2,029,875 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 142.37k | Mar 31, 2025 | 0.33% | 1,944,787 |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund | 77.69k | Mar 31, 2025 | 0.18% | 1,061,190 |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | 65.9k | Mar 31, 2025 | 0.15% | 900,193 |
| Fidelity Mt. Vernon Street Trust-Fidelity Series Growth Company Fund | 65.5k | Mar 31, 2025 | 0.15% | 894,729 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 48.33k | Mar 31, 2025 | 0.11% | 660,146 |
Related Tickers
MTSR Metsera, Inc.
29.35
+4.37%
AARD Aardvark Therapeutics, Inc.
11.66
+4.76%
SION Sionna Therapeutics, Inc.
14.48
+3.65%
BCAX Bicara Therapeutics Inc.
11.01
+11.21%
RAPP Rapport Therapeutics, Inc.
12.24
+30.21%
UPB Upstream Bio, Inc.
10.84
+1.69%
ALMS Alumis Inc.
3.4500
+4.86%
APGE Apogee Therapeutics, Inc.
37.08
+2.06%
TVTX Travere Therapeutics, Inc.
15.40
-0.77%
SEPN Septerna, Inc.
9.97
+0.40%